Press Releases

Sygnature Discovery establishes DEL screening collaboration with X-Chem

Johnson County ClinTrials (JCCT) Rebrands as Sequoia Clinical Research

New identity unites three site organizations under one banner as company expands beyond its vaccine-trial roots into multi-therapeutic clinical research site network

Astoriom Acquires Additional UK Storage Business to Expand Capacity and Service Offerings

• Acquisition of Sampled’s UK facility strengthens Astoriom’s position as a trusted provider of secure, compliant and quality-led sample stability and biorepository storage solutions • Offers broader coverage, additional technical expertise and increased operational resilience to help safeguard critical samples

New Veeva Study Builder Agent to Configure Clinical Studies in as Little as One Day

Veeva Systems today announced Veeva Study Builder Agent, a new AI solution that configures Veeva EDC and Veeva DQS (Data Quality System) directly from a study protocol.

New Publication Associates SherpaPak® Cardiac Transport System with Lower Costs Across Heart Transplant Care

Published in the special Focus Issue on Innovations in Heart Transplantation in the Journal of Cardiac Failure, the GUARDIAN-Heart analysis across 18 U.S. transplant centers identifies $14,982 in net per-patient cost savings across multiple measured categories spanning post-transplant support, hospital care, organ preservation, and readmissions.

BOC Sciences Announces October 2026 Webinars on Vaccine Development and DNA-Encoded Chemistry

Complex-molecule specialist Shilpa CDMO launches at CPHI Milan

Upperton granted MHRA licence for Annex 1 aligned sterile manufacturing facility

Upperton, a UK-based contract development and manufacturing organisation (CDMO), today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has approved a variation to its existing Manufacturing and Importation Authorisation for Investigational Medicinal Products (MIA(IMP)) licence, extending its scope to include the company’s new Annex 1-aligned sterile manufacturing facility at Trent Gateway, Nottingham.

TSRL, Inc. Rebrands as TSRLabs Ahead of Its Next Chapter of Growth

New name, visual identity and website position Ann Arbor preclinical CRO for its next phase of scientific growth

Psychedelic Medicines Approach a Historic FDA Approval Milestone with Safety Under Scrutiny

The FDA's historic psychedelic hearing highlighted a critical question: how can psychedelic medicines become accessible without compromising patient safety? As developers move closer to potential approvals, regulators must balance clinical evidence, professional oversight, workforce training, geographic access and long-term safety.

FDA Approves AstraZeneca’s Etcamah, Bringing ctDNA-Guided Treatment to Breast Cancer

AstraZeneca’s Etcamah has received FDA accelerated approval for ctDNA-guided treatment in HR-positive, HER2-negative breast cancer with ESR1 mutations. The decision could establish an earlier treatment-switch strategy based on molecular changes before cancer becomes visible on scans.

FibroFind appoints leading transplant physician Professor Andrew Fisher as Chief Medical Officer

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

Targeting a signal released by dormant cancer cells could help overcome resistance to immunotherapy and improve cellular therapies for pancreatic cancer.

Qinecsa selected as technology partner for Africa’s new continent-wide medicines safety platform

Qinecsa has been selected as technology partner for AfriVigilance, the African Medicines Agency’s new continent-wide medicines safety surveillance platform, with implementation already underway.

Panther Life Sciences Appoints Mounir Hanana as Chief Executive Officer

Hanana brings 25 years of experience scaling global technology, consumer, and manufacturing businesses at Amazon and Procter & Gamble. Founder Carlos Bhola continues as Executive Chairman, leading strategy, product vision and corporate development. Hanana joins as Panther begins commercializing its SmartPatch™ platform, starting with cosmetics and medical aesthetics and expanding to therapeutic applications.

Peer-Reviewed Study Published in MDPI’s AI Journal Shows NetraAI Uncovers Clinical Trial Signals Missed by Conventional AI and Foundation Models

The study evaluated NetraAI across clinical datasets in schizophrenia, major depressive disorder and pancreatic cancer, benchmarking the technology against eight industry-standard predictive models. Results show NetraAI's biological and clinical signatures successfully boosted the accuracy of all eight evaluated algorithms across every single dataset tested.

UT-led study finds COVID-19 can awaken hidden viruses throughout the body

Researchers say dormant viruses many people harbor can reactivate during COVID-19 and may be linked to long COVID symptoms.

Biocon Secures 10-Year Supply Contract for Pertuzumab in Brazil

Biocon has secured a 10-year PDP allocation for pertuzumab in Brazil through a partnership with Bahiafarma and Bionovis, covering around 70% of the country’s public-sector demand. The agreement combines long-term supply with phased local production, supporting affordable cancer treatment access and strengthening Brazil’s domestic biopharmaceutical capabilities.

CluePoints Launches Three AI-Led Clinical Data Review Capabilities, Co-Innovated with a Top 10 Pharmaceutical Company

Intelligent Query Detection, Medical & Safety Review and Intelligent Medical Coding are now generally available, extending CluePoints' science-first approach from RBQM into clinical data review. The partner will join CluePoints live at SCDM 2026 to celebrate the launch.

Yourgene Health Insight DPYD Assay Achieves IVDR Accreditation

Comprehensive pharmacogenetic testing solution aligned with latest clinical guidance to support informed chemotherapy treatment decisions